Guidelines: Management of Drug-resistant Tuberculosis

Guidelines: Management of Drug-resistant Tuberculosis

Updated January 2013, these South African Department of Health guidelines describe the management of drug-resistant (DR), multidrug-resistant (MDR) and extensively drug-resisistant tuberculosis (XDR-TB).

Read More

dept_of_health_logoThe guidelines begin by providing an overview of DR-TB in South Africa, including provincial data on confirmed cases MDR and XDR-TB cases between 2004 and 2010.

The document also briefly describes relevant national legislation protecting TB patients rights before outlining the structure of DR-TB management, including suggested staffing norms for both centralized and decentralized MDR-TB treatment and an organagram of decentralized treatment. As part of this, the guidelines provide brief summaries of the roles of individual health worker cadres.

The 172-page document also touches on infection control measures for patients at home and for health care workers conducting outreach visits, case-finding strategies and diagnostic principles.

Download the full guidelines:MDR-TB Clinical Guidelines (Updated Jan 2013)